(Reuters) -Eli Lilly hit $1 trillion in market value on Friday, making it the first drugmaker to enter the exclusive club dominated by tech giants and underscoring its rise as a weight-loss powerhouse.
Here are some reactions to Lilly joining the trillion dollar club:
EVAN SEIGERMAN, ANALYST AT BMO CAPITAL MARKETS
"The current valuation points to investor confidence in the longer-term durability of the company's metabolic health franchise. It also suggests that investors prefer Lilly over Novo in the obesity arms race. Taking a step back, we're also seeing money rotate into the sector as investors may be worried about an AI bubble."
HANK SMITH, DIRECTOR & HEAD OF INVESTMENT STRATEGY AT LILLY SHAREHOLDER HAVERFORD TRUST
"Investors have historically liked secure earnings growth and (Eli Lilly) is the only large cap pharma that has that kind of earnings profile."
(Reporting by Siddhi Mahatole and Shashwat Chauhan in Bengaluru; Editing by Leroy Leo)
latest_posts
- 1
Go With The Breeze: Grand Paragliding Spots On the planet - 2How to watch ‘The Traitors’ U.K. Season 4 from the U.S.
- 3The race to mine the moon is on – and it urgently needs some clear international rules
- 4Insurance warning signs in doctors’ offices might discourage patients from speaking openly about their health
- 5A Past filled with Old Civilizations: The World's Most established Societies
- Toyota Motor Europe to roll out smart EV charging through new partnerships
- Involved Vehicles for Seniors: Track down the Best Picks for Solace and Dependability
- The German series proving subtitles can be sexy — and wildly addictive
- Picking Your Next SUV: 4 Brands Offering Execution, Solace, and Wellbeing
- Vote in favor of Your #1 Home Exercise Gear: Execution and Comfort Matter
- Solar storms have influenced our history – an environmental historian explains how they could also threaten our future
- All that You Really want to Be aware of Dental Inserts Facilities
- Miley Cyrus details her fear of paper, says fiancé Maxx Morando opens their packages outside: 'That's really why I got engaged'
- Research institutions tout the value of scholarship that crosses disciplines – but academia pushes interdisciplinary researchers out
